FDA’s Vaccines & Related Biological Products Advisory Committee
Executive Summary
Panel will meet July 26 by telephone conference call to discuss the intramural scientific programs of CBER's Bacterial Toxins Lab and vaccine initiatives for FY 1994. The meeting will begin at 1 p.m. in conference room 121, FDA Building 29, Bethesda, Md.